7147-52-6Relevant academic research and scientific papers
Ruthenium(II)-catalyzed C-H arylation of anilides with boronic acids, borinic acids and potassium trifluoroborates
Hubrich, Jonathan,Himmler, Thomas,Rodefeld, Lars,Ackermann, Lutz
supporting information, p. 474 - 480 (2015/03/05)
An in situ generated cationic ruthen-ium(II) catalyst allowed for robust C-H arylations of anilides with boronic acids. The optimized ruthenium catalyst was found to be both site selective and chemoselective, thereby providing the monoarylated products in
Ruthenium-catalyzed ortho-arylation of acetanilides with aromatic boronic acids: An easy route to prepare phenanthridines and carbazoles
Chinnagolla, Ravi Kiran,Jeganmohan, Masilamani
supporting information, p. 2442 - 2444 (2014/03/21)
The highly regioselective ortho-arylation of acetanilides with aromatic boronic acids in the presence of a Ru(ii) complex (3 mol%), AgSbF6 (12 mol%), Cu(OTf)2 (20 mol%) and Ag2O (1.0 eq.) is described. Later, ortho-arylated acetanilides were converted into phenanthridine and carbazole derivatives by using Ph3PO and Tf2O or palladium or Cu(OTf)2 catalysts.
QUATERNARY AMMONIUM SALT COMPOUNDS
-
Page/Page column 35, (2012/03/10)
[Problem] The object of the present invention is to provide a novel compound having 132 adrenergic receptor agonist activity and muscarinic receptor antagonist activity. [Means for Solving the Problem] The present invention is a quaternary ammonium salt compounds represented by formula (I), or a pharmaceutically acceptable salt thereof, with superior β32 adrenergic receptor agonist activity and muscarinic receptor antagonist activity.
